High risk genes predisposing to prostate cancer development—do they exist?

被引：0
|
作者：
R Singh
RA Eeles
F Durocher
J Simard
S Edwards
M Badzioch
Z Kote-Jarai
D Teare
D Ford
D Dearnaley
A Ardern-Jones
A Murkin
A Dowe
R Shearer
J Kelly
F Labrie
D Easton
SA Narod
PN Tonin
WD Foulkes
机构：
[1] Institute of Cancer Research,Department of Medicine
[2] Royal Marsden NHS Trust,Division of Medical Genetics
[3] Laboratory of Molecular Endocrinology,undefined
[4] CHUL Research Center,undefined
[5] MD Anderson Cancer Centre,undefined
[6] CRC Genetic Epidemiology Unit,undefined
[7] Strangeways Research Laboratories,undefined
[8] Centre for Research in Women's Health,undefined
[9] Montreal General Hospital,undefined
[10] Box 35 7720,undefined
[11] University of Washington Medical Center,undefined
[12] Seattle,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2000年 / 3卷
关键词：
prostate cancer; genetics; high risk genes; low risk genes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
There is evidence for genetic predisposition to prostate cancer. However, prostate cancer genes have been more difficult to find than genes for some of the other common cancers, such as breast and colon cancer. The reasons for this are discussed in this article and it is now becoming clear that prostate cancer is probably due to multiple genes, many of which are moderate or low penetrance. The advances in the Human Genome Project and technology, especially that of robotics, will help to overcome these problems.
引用
收藏
页码：241 / 247
页数：6
相关论文
共 50 条
  • [31] Do racial disparities exist in the use of prostate cancer screening and detection tools in veterans?
    Hudson, M'Liss A.
    Luo, Suhong
    Chrusciel, Timothy
    Yan, Yan
    Grubb, Robert L., III
    Carson, Kenneth
    Scherrer, Jeffrey F.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2014, 32 (01) : 34.e9 - 34.e18
  • [32] Development of intermediate and high-risk prostate cancer after testicular cancer.
    Riggin, Andrew John
    Siddiqui, Mohummad Minhaj
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [33] The effect of neighborhood social environment on prostate cancer development in black and white men at high risk for prostate cancer
    Lynch, Shannon M.
    Handorf, Elizabeth
    Sorice, Kristen A.
    Blackman, Elizabeth
    Bealin, Lisa
    Giri, Veda N.
    Obeid, Elias
    Ragin, Camille
    Daly, Mary
    PLOS ONE, 2020, 15 (08):
  • [34] Optimal timing of radiotherapy in high risk prostate cancer: Do missed days matter?
    Hasan, Shaakir
    Gorovets, Daniel
    Lehrer, Eric J.
    Lazarev, Stanislav
    Press, Robert H.
    Garg, Madhur
    Mehta, Keyur J.
    Chhabra, Arpit M.
    Choi, J. Isabelle
    Simone, Charles B., II
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2021, 26 : 47 - 54
  • [35] Do metformin and statins play a role in localized high-risk prostate cancer?
    Cadeddu, G.
    Lopez Campos, F.
    Martin Martin, M.
    Pelari Mici, L.
    Charahua de Kirschner, K. Ytuza
    Hernandez Corrales, A.
    Carrasco Esteban, E.
    Sastre Gallego, S.
    Ciscar Garcia, I.
    Sancho Garcia, S.
    Hervas Moron, A.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S841 - S841
  • [36] Defining and Treating High-Risk Prostate Cancer: Can We Do Better?
    Gerber, Leah
    Banez, Lionel L.
    Freedland, Stephen J.
    EUROPEAN UROLOGY, 2010, 58 (01) : 8 - 9
  • [37] RELATION BETWEEN MUTATIONS IN PROSTATE CANCER AND FAMILIAL HISTORY OF CANCER PREDISPOSING GENES WITH THE AGE OF PROSTATE CANCER PATIENTS AT THE TIME OF DIAGNOSIS - IMPACT ON SCREENING INDICATIONS
    Antczak, Andrzej
    Stawicka, Malgorzata
    Izycki, Dariusz
    Godlewski, Dariusz
    Cybulski, Cezary
    Milecki, Piotr
    Kwias, Zbigniew
    JOURNAL OF UROLOGY, 2009, 181 (04): : 657 - 657
  • [38] PREDISPOSING FACTORS TO THROMBOEMBOLISM IN PATIENTS WITH CANCER OF THE PROSTATE
    BENOIT, G
    MAISONNEUVE, P
    TALLEY, F
    LIMOUSINLAMOTHE, MA
    SULTAN, Y
    STEG, A
    THROMBOSIS AND HAEMOSTASIS, 1981, 46 (01) : 402 - 402
  • [39] Variation in selenoenzyme genes and prostate cancer risk and survival
    Geybels, Milan S.
    Hutter, Carolyn M.
    Kwon, Erika M.
    Ostrander, Elaine A.
    Fu, Rong
    Feng, Ziding
    Stanford, Janet L.
    Peters, Ulrike
    PROSTATE, 2013, 73 (07): : 734 - 742
  • [40] Risk of prostate cancer in relation to polymorphisms of metabolic genes
    Chen, C
    EPIDEMIOLOGIC REVIEWS, 2001, 23 (01) : 30 - 35
12345